Integrated care to improve biopsychosocial outcomes after early liver transplant for alcohol-related liver disease
2/4-The INTEGRATE Study: Evaluating INTEGRATEd care to Improve Biopschosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease
The team tests whether combining alcohol-use disorder treatment with transplant care helps people with alcohol-related liver disease who receive early liver transplants stay sober and do better after surgery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11169937 on NIH RePORTER |
What this research studies
You would join a multicenter effort that follows people with alcohol-associated liver disease who are evaluated for early liver transplant. The project collects medical records plus standardized questionnaires about mental health, alcohol use, social supports, and other biopsychosocial factors before and after transplant. Researchers will build risk prediction models for key patient-centered outcomes and compare outcomes across centers with different levels of integrated AUD and transplant care. Patient and stakeholder input is included to make sure findings apply across diverse racial, cultural, and socioeconomic groups.
Who could benefit from this research
Good fit: Adults with alcohol-associated liver disease who are being evaluated for or receiving an early liver transplant (typically with less than six months of abstinence) are the intended candidates.
Not a fit: People without alcohol-related liver disease, those not undergoing transplant evaluation, or those already stably abstinent long before evaluation are unlikely to be eligible or benefit directly from this project.
Why it matters
Potential benefit: If successful, this work could help more people maintain sobriety, improve survival and quality of life after transplant, and guide fairer access to early liver transplantation.
How similar studies have performed: Retrospective studies suggest acceptable outcomes for early liver transplant in alcohol-associated hepatitis, but prospective, multicenter testing of integrated addiction and transplant care is largely new.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Verna, Elizabeth Clarice — Columbia University Health Sciences
- Study coordinator: Verna, Elizabeth Clarice
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.